PUBLIC CONTRACT · 2020
41005620 - AQ Urgente Medicamentos
- Contract value
- €55,226.98
- Signed on
- 10 February 2020
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 6346900PUBLISHED SUBJECT
Atezolizumab 60 mg/ml Sol inj Fr 20 ml IV Cladribina 10 mg comp. AZACITIDINA 100 MG PÓ SUSP INJ
Parties involved
- Place of performance
- Portugal, Setúbal, Setúbal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Merck Sharp Dohme · Tax ID 500191360
- Awardee
- CELGENE SOCIEDADE UNIPESSOAL LDA · Tax ID 507791690
- Awardee
- ROCHE FARMACEUTICA QUIMICA, LDA · Tax ID 500233810
Values and timeline
- Contract price
- €55,226.98
- Procedure base price
- €55,226.98
- Total effective price
- Not reported on Portal BASE
- Publication date
- 20 February 2020
- Award date
- 10 February 2020
- Signing date
- 10 February 2020
- Performance period
- 10 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 24.º, n.º 1, alínea c) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4424096
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.